Mark R. Lovern, PhDSenior Vice President, Product & Commercial Strategy, Simcyp Division
Dr Mark Lovern joined Certara (then Quantitative Solutions) in 2012 and has 25+ years of experience in the application of model-informed drug development (MIDD). Throughout his career, Mark has led and contributed to numerous projects involving quantitative pharmacology. Mark’s current role is SVP of commercial and product strategy for Certara’s Simcyp business unit. Immediately prior to his present position, Mark led Certara’s Quantitative Science Services for the United States. His previous work history has been split between Biopharmaceutical companies (GSK and UCB) and companies that support the Biopharmaceutical industry (Quintiles and Pharsight.) In addition to modeling pharmacokinetic and pharmacodynamic data across a wide variety of compounds and therapeutic areas, Mark has also taught over 50 technical training workshops on modeling tools and methodology. His most recent therapeutic area experience has been with therapies for infectious disease, metabolic, and autoimmune disorders.
Mark was awarded a Ph. D. in Biomathematics form North Carolina State University in 1997. His favorite leisure activities include hosting dinner parties, traveling, reading, and enjoying films.